Beth Israel Deaconess Medical Center · Harvard Medical School

The Division of Digital Psychiatry

Improving the quality and accessibility of mental health treatment through education, research, and innovation in digital psychiatry.

Who We Are

The Division of Digital Psychiatry is a collaborative research group at Beth Israel Deaconess Medical Center, a Harvard Medical School affiliate in Boston, MA. Our team of mental health professionals with backgrounds in medicine, engineering, and clinical care works to improve the quality and accessibility of treatment for mental illness.

Collect

We capture the real-time lived experiences of patients with mindLAMP, our open-source platform for digital phenotyping and mobile interventions.

Interpret

We draw insights from novel digital data and analyze emerging health policy, from app evaluation frameworks to machine learning models.

Implement

We deliver care and empower digital equity through our Digital Clinic,DOORS program, and community partnerships.

Currently Enrolling

All studies

Personalized Recommendations for Social Media Detox

Recruiting

A 5-week remote study investigating how reducing social media usage impacts mood, sleep, and overall mental health in young adults.

Social MediaSleepMood
Learn more & participate
AI

Beyond artificial intelligence psychosis: a functional typology of large language model-associated psychotic phenomena

Flathers M, Roux S, Torous J

The Lancet. Digital health · 2026

A man breached Windsor Castle with a crossbow after his large language model (LLM)-based companion encouraged an assassination plan. A father's question about pi evolved into more than 300 h of engagement with an LLM, leading to delusions about reality-altering mathematical formulas. An Australian woman's early-stage psychotic symptoms worsened when an LLM validated her distorted beliefs. A Florida man's grief over losing access to his ChatGPT persona culminated in a fatal police encounter. These disparate cases, often grouped together under the label of artificial intelligence psychosis, represent distinct phenomena requiring different clinical and technological interventions. This Viewpoint, co-written by a software engineer, a person with lived experience of schizophrenia, and a psychiatrist, proposes a functional typology of LLM-associated psychotic phenomena, based on the system's role: catalyst (precipitating new symptoms in previously healthy individuals), amplifier (worsening pre-existing psychiatric symptoms), coauthor (participating in the development of harmful narratives), or object (becoming the focus of delusional beliefs). By distinguishing functional roles rather than assuming a unified phenomenon, this typology allows clinicians to identify concerning LLM usage patterns and technology companies to develop specific safeguards, moving beyond sensationalised terminology towards mechanism-specific interventions.